Quantitative proteomic analysis of serum from pregnant women carrying a fetus with conotruncal heart defect using isobaric tags for relative and absolute quantitation (iTRAQ) labeling.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4230941)

Published in PLoS One on November 13, 2014

Authors

Ying Zhang1, Yuan Kang1, Qiongjie Zhou1, Jizi Zhou1, Huijun Wang2, Hong Jin3, Xiaohui Liu4, Duan Ma5, Xiaotian Li6

Author Affiliations

1: Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China.
2: Children's Hospital, Fudan University, Shanghai, China.
3: Department of Chemistry, Fudan University, Shanghai, China; Institute of Biomedicine, Fudan University, Shanghai, China.
4: Department of Chemistry, Fudan University, Shanghai, China.
5: Key Laboratory of Molecular Medicine, Ministry of Education, Department of Biochemistry and Molecular Biology, Institute of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.
6: Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China; Key Laboratory of Molecular Medicine, Ministry of Education, Department of Biochemistry and Molecular Biology, Institute of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China; Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shanghai, China.

Articles cited by this

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81

The incidence of congenital heart disease. J Am Coll Cardiol (2002) 16.13

Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation (2007) 4.34

An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol (1984) 4.10

Racial and temporal variations in the prevalence of heart defects. Pediatrics (2001) 2.88

Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers. JAMA (2004) 2.53

Proteomic identification of serum peptides predicting subsequent spontaneous preterm birth. Am J Obstet Gynecol (2010) 2.37

The usefulness of brain natriuretic peptide in complex congenital heart disease: a systematic review. J Am Coll Cardiol (2012) 2.27

Neural crest and cardiovascular patterning. Circ Res (1995) 2.11

Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays. Circulation (2000) 2.04

Maternal MTHFR 677C>T is a risk factor for congenital heart defects: effect modification by periconceptional folate supplementation. Eur Heart J (2006) 1.84

Neural crest and cardiovascular development: a 20-year perspective. Birth Defects Res C Embryo Today (2003) 1.79

Pathogenetic mechanisms of congenital cardiovascular malformations revisited. Semin Perinatol (1996) 1.51

Antenatal screening for Down's syndrome. J Med Screen (1997) 1.32

Quantitative proteomics analysis of maternal plasma in Down syndrome pregnancies using isobaric tagging reagent (iTRAQ). J Biomed Biotechnol (2009) 1.25

Congenital heart disease in pregnancies complicated by maternal diabetes mellitus. An international clinical collaboration, literature review, and meta-analysis. Herz (2010) 1.15

Loss of Gelsolin expression in human ovarian carcinomas. Eur J Cancer (2005) 1.07

Trends in infant mortality attributable to birth defects--United States, 1980-1995. MMWR Morb Mortal Wkly Rep (1998) 1.04

Downregulation of gelsolin correlates with the progression to breast carcinoma. Breast Cancer Res Treat (2001) 1.03

Downregulated gelsolin expression in hyperplastic and neoplastic lesions of the prostate. Prostate (1999) 1.01

In colon carcinogenesis, the cytoskeletal protein gelsolin is down-regulated during the transition from adenoma to carcinoma. Hum Pathol (2008) 0.99

Familial non-syndromic conotruncal defects are not associated with a 22q11 microdeletion. Hum Genet (1996) 0.98

Application of proteomics for the identification of differentially expressed protein markers for Down syndrome in maternal plasma. Prenat Diagn (2008) 0.96

In vivo administration of calpeptin attenuates calpain activation and cardiomyocyte loss in pressure-overloaded feline myocardium. Am J Physiol Heart Circ Physiol (2008) 0.93

Microarray analysis of Tbx5-induced genes expressed in the developing heart. Dev Dyn (2006) 0.93

Fetal echocardiography: 20 years of progress. Heart (2001) 0.93

Proteome analysis of human amnion and amniotic fluid by two-dimensional electrophoresis and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proteomics (2006) 0.92

Therapeutic potential of plasma gelsolin administration in a rat model of sepsis. Cytokine (2011) 0.91

Overexpression of gelsolin in human cervical carcinoma and its clinicopathological significance. Gynecol Oncol (2010) 0.90

Diagnostic, prognostic and therapeutic relevance of B-type natriuretic hormone and related peptides in children with congenital heart diseases. Clin Chem Lab Med (2011) 0.89

Efficacy of fetal echocardiography and yield by risk category. Obstet Gynecol (1996) 0.88

Proteomic study reveals plasma protein changes in congenital heart diseases. Ann Thorac Surg (2014) 0.86

Serum profile in preeclampsia and intra-uterine growth restriction revealed by iTRAQ technology. J Proteomics (2010) 0.86

Proteomic analysis of amniotic fluid in pregnancies with Klinefelter syndrome foetuses. J Proteomics (2010) 0.86

Periconceptional nutrient intakes and risks of conotruncal heart defects. Birth Defects Res A Clin Mol Teratol (2010) 0.85

Network analyses of differentially expressed proteins in amniotic fluid supernatant associated with abnormal human karyotypes. Fertil Steril (2008) 0.85

New understandings in the genetics of congenital heart disease. Curr Opin Pediatr (1996) 0.85

Change in plasma gelsolin level after traumatic brain injury. J Trauma Acute Care Surg (2012) 0.84

Novel pathophysiological markers are revealed by iTRAQ-based quantitative clinical proteomics approach in vascular dementia. J Proteomics (2014) 0.83

Conotruncal anomalies in fetal life: accuracy of diagnosis, associated defects and outcome. Eur J Obstet Gynecol Reprod Biol (2009) 0.83

Quantitative proteomic analysis of serum proteins in patients with Parkinson's disease using an isobaric tag for relative and absolute quantification labeling, two-dimensional liquid chromatography, and tandem mass spectrometry. Analyst (2011) 0.83

Maternal serum proteome changes between the first and third trimester of pregnancy in rural southern Nepal. Placenta (2012) 0.82

Proteomic analysis of amniotic fluid in pregnancies with Turner syndrome fetuses. J Proteome Res (2008) 0.81

Epidemiology of nonsyndromic conotruncal heart defects in Texas, 1999-2004. Birth Defects Res A Clin Mol Teratol (2010) 0.81

Discovery of the serum biomarker proteins in severe preeclampsia by proteomic analysis. Exp Mol Med (2011) 0.80

Changes in amniotic fluid and umbilical cord serum proteomic profiles of foetuses with intrauterine growth retardation. Electrophoresis (2011) 0.80

Potential biomarkers for Turner in maternal plasma: possibility for noninvasive prenatal diagnosis. J Proteome Res (2010) 0.79

Identification of novel candidate maternal serum protein markers for Down syndrome by integrated proteomic and bioinformatic analysis. Prenat Diagn (2012) 0.79

Gelsolin (GSN) induces cardiomyocyte hypertrophy and BNP expression via p38 signaling and GATA-4 transcriptional factor activation. Mol Cell Biochem (2014) 0.78

Gelsolin down-regulates lipopolysaccharide-induced intraamniotic tumor necrosis factor-alpha production in the midtrimester of pregnancy. Am J Obstet Gynecol (2008) 0.78

Decreased plasma gelsolin is associated with 1-year outcome in patients with traumatic brain injury. J Crit Care (2012) 0.78

Proteomic identification of serum peptides predicting subsequent spontaneous preterm birth. Am J Obstet Gynecol (2011) 0.78

iTRAQ-based proteomic profiling of human serum reveals down-regulation of platelet basic protein and apolipoprotein B100 in patients with hematotoxicity induced by chronic occupational benzene exposure. Toxicology (2011) 0.77

The association between plasma gelsolin level and prognosis of burn patients. Burns (2014) 0.76

The natriuretic peptides as biomarkers for adults with congenital heart disease. Biomark Med (2012) 0.76

Angioarchitecture of the venous and capillary system in heart defects induced by retinoic acid in mice. Birth Defects Res A Clin Mol Teratol (2009) 0.76